The Windsor Framework is a political agreement between the European Commission and the U.K. government to ensure that, in the wake of Brexit, Northern Ireland continues to receive critical supplies such as food and medicines. This past week, the MHRA provided guidance on labeling of medicines destined for Northern Ireland, with provisions to ensure that medicines only move into Northern Ireland market and don’t re-enter E.U. member states.
Background
The U.K.’s official exit from the E.U. on February 1, 2020 started a year-long transition period; the E.U. pharmaceutical law ceased to apply to the U.K. as of January 1, 2021.
Fill out the form to read the full article.
